ReviewSubstance use & misuse2005
Pharmacotherapy of alcohol use disorders.
Review in Substance use & misuse, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Jack of all trades inhibits inflammation (in sober people).Nature immunology · 2020Article
- Medications for substance use disorders.Social work in public health · 2013Review
- Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety.The Journal of pharmacology and experimental therapeutics · 2010Article
- Withdrawal from free-choice high-fat high-sugar diet induces craving only in obesity-prone animals.Psychopharmacology · 2009Article
- Practitioner review: adolescent alcohol use disorders: assessment and treatment issues.Journal of child psychology and psychiatry, and allied disciplines · 2008Review
- Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2008Review
- Between- and within-family association test of the dopamine receptor D2 TaqIA polymorphism and alcohol abuse and dependence in a general population sample of adults.Journal of studies on alcohol and drugs · 2007Article
- Alcohol use and misuse.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2007Article
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Therapeutic interventions to treat alcoholism have increased in number, including several pharmacotherapies. Aspects of epidemiology, gender, and psychiatric comorbidity as well as a brief overview of neurobiology are presented as an introduction. The medications used clinically for the treatment of alcoholism, disulfiram and naltrexone, approved by the Food and Drug Administration in the United States for the treatment of alcoholism and acamprosate, a medication used extensively in Europe that is currently being evaluated in the United States, are reviewed in detail. An overview of the serotonergic agents is also provided. Finally, future directions, including new medications and some clinical strategies that show promise but are not yet used extensively clinically, are mentioned.
Indexed as
Identifiers
16282090What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.